Research peptidesFirst Choice Peptide Group
FCPG · 01 GLP-1 RESEARCHFCPG-R3RetatrutideCAS2381089-83-2MF—MW—5 MG · 10 MG · 15 MG +3FCPGFCPG-R35 mgLYOPHILIZED · RUORESEARCH USE ONLYFOR RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
  • Research use only
  • Store −20 °C

01 · GLP-1 Research

FCPG-R3

Retatrutide

Triple GIP / GLP-1 / glucagon receptor agonist research compound.

CAS number
2381089-83-2
Molecular weight
Not listed
Molecular formula
Not listed
Form
Lyophilized powder

$25 per vial

Size
Volume pricing · per vial, counted across your whole order

SKU FCPG-RETA-5

Free U.S. shipping over $150

Crypto or ACH: a further 3% off

Overview

Retatrutide is a triple agonist research compound at the GIP, GLP-1, and glucagon receptors. Research literature examines its multi-receptor pharmacology and the integrated signaling profile relevant to metabolic-pathway research.

We do not provide use guidance of any kind. For research methodology, we recommend the published literature on the compound of interest via PubMed or an equivalent database.

Specifications

ProductFCPG-R3 (Retatrutide)
CategoryGLP-1 Research
CAS number2381089-83-2
Molecular formulaNot listed
Molecular weightNot listed
Formats5 mg · 10 mg · 15 mg · 20 mg · 30 mg · 60 mg
FormLyophilized powder
StorageStore lyophilized material at −20 °C, desiccated and protected from light. Let the sealed vial reach room temperature before opening to limit condensation. Once reconstituted, keep at 2–8 °C.

Handling & storage

Store lyophilized material at −20 °C, desiccated and protected from light. Let the sealed vial reach room temperature before opening to limit condensation. Once reconstituted, keep at 2–8 °C.

For concentration, molarity and aliquot arithmetic, use the reconstitution & concentration calculator. Handle all materials under your institution's laboratory safety procedures.

01 · GLP-1 Research

Related compounds.

View the category